ETFs - Profile

Principal Healthcare Innovators Index ETF

US > Health/Biotechnology >

Rank

Universe Rank
20 21

Summary

The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies in the United States.

The fund employs a passive investment approach designed to attempt to track the performance of the Index.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests significantly in equity securities of companies that compose the Index.

The Index is designed to identify equity securities in the More

Philosophy Strategy Process Reaserch Risk Management

Price

  • Last Close
  • $54.63
    +0.72
  • 52 Week HL
  • $70.78 - $46.81
  • Net Assets
  • Expense Ratio

Portfolio

  • Holdings
  • -
  • Turnover Ratio
  • -

Performance
-6.6 % YTD

  • 3 Year
  • 97.93%
  • 5 Year
  • 108.07%
  • Best
  • 51.72%
    2020
  • Worst
  • -12.24%
    2018

Returns +
A

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
BTEC -7%52%40%-12%37%0%0%0%0%0%0%
S&P 500 19%16%29%-6%19%10%-1%11%30%13%0%

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 -1.2% -18.4% 26.1% 3.7% 16% - - - - - -
Q2 5.1% 42% -2.4% 12.6% 7.4% -100% - - - - -
Q3 -7.2% 6.7% -10.2% 6.9% 6.8% 3.1% - - - - -
Q4 - 22.7% 24.6% -25% 1.3% -12.6% - - - - -

Returns +
M

J F M A M J J A S O N D
2021 8.4% -1.3% -7.7% 5.4% -10.8% 11.7% -6.6% 1.8% -5.4% - - -
2020 -1.6% -2.8% -14.7% 22.1% 8.7% 7% 5.5% -4.3% 5.6% 1% 16.4% 4.3%

Annual Return

Index Comparison

Alpha

NAV